Interferon-α in acute myeloid leukemia: an old drug revisited.
about
Genetic engineering of hematopoiesis for targeted IFN-α delivery inhibits breast cancer progressionMaintenance therapy in acute myeloid leukemia: an evidence-based review of randomized trials.Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.miR-155 promotes FLT3-ITD-induced myeloproliferative disease through inhibition of the interferon responseInterleukin-15-induced CD56(+) myeloid dendritic cells combine potent tumor antigen presentation with direct tumoricidal potential.Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patientsReovirus-mediated cytotoxicity and enhancement of innate immune responses against acute myeloid leukemia.The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of hematologic malignancies: multiple myeloma, lymphoma, and acute leukemia.RUNX1-ETO induces a type I interferon response which negatively effects t(8;21)-induced increased self-renewal and leukemia development.A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms.Natural killer cell immune escape in acute myeloid leukemia.Leukemia-associated antigens and their relevance to the immunotherapy of acute myeloid leukemia.Regulation of self-renewal in normal and cancer stem cells.Interferon α may be back on track to treat acute myeloid leukemia.Crosstalk between dendritic cell subsets and implications for dendritic cell-based anticancer immunotherapy.Immunotherapy in acute myeloid leukemia.Macrophage-based cell therapies: The long and winding roadPreventing relapse after haematopoietic stem cell transplantation for acute leukaemia: the role of post-transplantation minimal residual disease (MRD) monitoring and MRD-directed intervention.STING Pathway Activation Stimulates Potent Immunity against Acute Myeloid Leukemia.Cooperative TRAIL production mediates IFNα/Smac mimetic-induced cell death in TNFα-resistant solid cancer cells.Comparison of outcomes after donor lymphocyte infusion with or without prior chemotherapy for minimal residual disease in acute leukemia/myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation.Engineering monocyte-derived dendritic cells to secrete interferon-α enhances their ability to promote adaptive and innate anti-tumor immune effector functions.Central nervous system involvement of epstein barr virus associated lymphoproliferative disorder in a child with acute lymphoblastic leukemia: successful treatment with rituximab and interferon-alpha.Host–guest interactions in polycationic human serum albumin bioconjugates
P2860
Q28304978-73DE0CCE-C309-40E8-8C34-7A2ED8C4568EQ30249246-924E8661-A3C3-4E1B-BA94-405F69D8EFC6Q33657377-B0D9E3B1-EADF-4980-85F3-C94A621F479EQ33782332-4BADD5D2-8645-4071-8BF9-157553124EEFQ34532389-B189A7BC-2572-4422-BB38-060439DFD4E8Q35996170-22E8F51E-47DC-415B-A8B2-A551ADB482B3Q36574519-8D522621-743E-49D0-B6D4-B180E42C41E3Q37517482-D50FECDF-70BA-436A-8DB3-9269E9E233A4Q37704367-9B9287D7-41AA-4E8F-A2C8-7A18A4710185Q37955231-186DCCB2-541D-4C5B-B127-67A638907617Q37996816-B4EF39DF-D7DE-4E3E-B3B0-3A7314C3BBAEQ38015123-10A1F30C-B7A9-408E-85F8-8040B4108153Q38030660-A44138A9-50E0-47FC-ABC0-E1081F806849Q38111770-B3E5695D-62CB-4A7E-8D2E-B8D2316E5CBDQ38206571-87163FB2-0AB0-44F0-A6CA-25940B7A6331Q38533606-DD7AD63D-E82F-4473-B4C6-3146CB9A947EQ38898549-834F5001-7E75-4D56-9851-92473684B9D1Q39329093-E54A4E47-B8AD-4323-B490-76D4F6B329D3Q39708605-BCA7D88D-F5A5-445E-8F71-E29E57800CC3Q39996056-E72E5C9E-23CC-4A1E-9046-263C0A208552Q40296180-613804FD-E93D-4B8F-96C3-4B10357903B3Q41343094-F83FFC42-E293-4933-B4C1-A40FE0FD59EDQ42245545-3E09E21D-62B8-4ECA-8567-76D682E70BF3Q58202930-3E76EBAC-94FA-48C8-A41D-11BE5D973676
P2860
Interferon-α in acute myeloid leukemia: an old drug revisited.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interferon-α in acute myeloid leukemia: an old drug revisited.
@en
Interferon-α in acute myeloid leukemia: an old drug revisited.
@nl
type
label
Interferon-α in acute myeloid leukemia: an old drug revisited.
@en
Interferon-α in acute myeloid leukemia: an old drug revisited.
@nl
prefLabel
Interferon-α in acute myeloid leukemia: an old drug revisited.
@en
Interferon-α in acute myeloid leukemia: an old drug revisited.
@nl
P2093
P2860
P356
P1433
P1476
Interferon-α in acute myeloid leukemia: an old drug revisited.
@en
P2093
E L J M Smits
S Anguille
V F I Van Tendeloo
Y Willemen
Z N Berneman
P2860
P2888
P304
P356
10.1038/LEU.2010.324
P577
2011-01-28T00:00:00Z
P6179
1006860601